Clal Biotechnology Industries Ltd. (TLV: CBI)
Israel
· Delayed Price · Currency is ILS · Price in ILA34.80
-0.80 (-2.25%)
Dec 19, 2024, 5:24 PM IDT
TLV: CBI Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -74.74 | -31.05 | -61.74 | -89.58 | 109.03 | -154.11 | Upgrade
|
| Depreciation & Amortization | 0.44 | 0.53 | 17.64 | 22.51 | 23.87 | 21.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 1.57 | - | -22.37 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 26.47 | 278.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | 31.61 | -3 | 8.03 | 31.15 | -137.14 | -7.06 | Upgrade
|
| Loss (Gain) on Equity Investments | 27.8 | 17 | 22.39 | 30.81 | 28.94 | 71.42 | Upgrade
|
| Stock-Based Compensation | -0.22 | 0.04 | 5.15 | 5.55 | 5.54 | 6.5 | Upgrade
|
| Other Operating Activities | 7.01 | 6.77 | -31.76 | -43.92 | -65.81 | -201.12 | Upgrade
|
| Change in Accounts Receivable | 0.82 | 1.02 | -6.61 | 2.02 | 3.16 | 10.09 | Upgrade
|
| Change in Inventory | - | - | -2.25 | 0.58 | 0.73 | 0.35 | Upgrade
|
| Change in Accounts Payable | - | - | -4.2 | 5.5 | -3.82 | 4.46 | Upgrade
|
| Change in Other Net Operating Assets | -0.78 | 0.19 | -7.26 | -5.93 | -1.83 | -3.2 | Upgrade
|
| Operating Cash Flow | -8.05 | -8.51 | -59.04 | -41.33 | -33.23 | 27.03 | Upgrade
|
| Capital Expenditures | - | -0.01 | -1.27 | -1.59 | -3.19 | -2.83 | Upgrade
|
| Divestitures | - | - | -9.52 | - | -1.48 | - | Upgrade
|
| Investment in Securities | 15.15 | 6.84 | -0.18 | 80.66 | 74.12 | -21.31 | Upgrade
|
| Other Investing Activities | 1.6 | 0.83 | 0.02 | 0.12 | 1.33 | 0.62 | Upgrade
|
| Investing Cash Flow | 16.75 | 7.66 | -10.96 | 79.18 | 70.78 | -23.52 | Upgrade
|
| Long-Term Debt Repaid | - | -1.16 | -2.51 | -2.42 | -1.75 | -2.76 | Upgrade
|
| Net Debt Issued (Repaid) | -9.59 | -1.16 | -2.51 | -2.42 | -1.75 | -2.76 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -9.74 | -0.26 | - | Upgrade
|
| Common Dividends Paid | - | - | - | -36 | - | - | Upgrade
|
| Other Financing Activities | -3.16 | -0.03 | 22.56 | -3.38 | -0.37 | 0.25 | Upgrade
|
| Financing Cash Flow | -12.75 | -1.18 | 20.05 | -51.54 | -2.38 | -2.52 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.28 | 0.32 | 4.33 | -1.42 | -4.57 | -3.8 | Upgrade
|
| Net Cash Flow | -3.78 | -1.71 | -45.61 | -15.11 | 30.61 | -2.82 | Upgrade
|
| Free Cash Flow | -8.05 | -8.52 | -60.31 | -42.92 | -36.41 | 24.2 | Upgrade
|
| Free Cash Flow Margin | -25159.38% | -8190.38% | -16300.00% | -19160.71% | -17675.24% | 21.36% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.38 | -0.27 | -0.23 | 0.15 | Upgrade
|
| Cash Interest Paid | 3.29 | 0.25 | 0.31 | 0.49 | 0.52 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.09 | - | - | Upgrade
|
| Levered Free Cash Flow | -7.4 | -5.44 | 6.26 | 23.33 | 10.79 | 26.93 | Upgrade
|
| Unlevered Free Cash Flow | -5.05 | -3.22 | 8.59 | 24.43 | 10.79 | 36.38 | Upgrade
|
| Change in Net Working Capital | 0.2 | -2.58 | 5.11 | -5.87 | 8.78 | -19.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.